Announcement: Presentation at “GTB BioStartup Connect”

We are pleased to announce that Makoto Yamamoto, CEO will present at “GTB / JBA / JETRO BioStartup Pitch – GTB BioStartup Connect” on December 11, 2025.

This event is jointly hosted by the Greater Tokyo Biocommunity (GTB), Japan Bioindustry Association (JBA), and JETRO, bringing together leading seed to Series C drug discovery startups.

Our presentation will highlight our novel nucleic acid technology that induces cancer cell death and activates cancer immunity, forming a next-generation oncology therapeutic platform.

The program also features a keynote by Stephanie Wisner, author of “Building Backwards: Lessons for Biotech Startups,” followed by networking and poster sessions.

We look forward to sharing our progress and connecting with the biotech community.